Literature DB >> 3810037

Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients.

J P Naets, J F Garcia, C Tousaaint, M Buset, D Waks.   

Abstract

The erythropoietin (Ep) plasma titre of 41 anaemic patients with normal renal function or with renal insufficiency (with or without kidney) was measured by RIA and compared to values observed with the polycythaemic mouse assay. A good correlation was found with both methods (r = 0.88). However, about 20% of samples gave higher values with the bioassay. 21 Ep titres measurable by the bioassay ranged from 40 to 4400 mU (mean 717.1 mU) compared to 14.8 to 3788 mU (mean 484.7 mU) measured by the RIA. Low levels of Ep plasma titre have been observed in patients with renal insufficiency and no difference was found between nephric uraemic patients and the anephric group. These results suggest that the increased blood requirements in anephrics are not due to a smaller production of Ep, but ultimately to the presence of an inhibitor of erythropoiesis. The well-known inverse relationship between haematocrit and Ep level was not found in renal insufficiency. However, some humoral regulation of erythropoiesis seems to persist in these patients since the elevation of red blood cells by transfusions was followed by a decrease of the Ep level.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3810037     DOI: 10.1111/j.1600-0609.1986.tb02626.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  Erythropoietin: the developing story.

Authors:  P M Cotes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

2.  The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.

Authors:  T Salmonson; B G Danielson; B Wikström
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

Review 3.  Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.

Authors:  Ashraf Mikhail; Christopher Brown; Jennifer Ann Williams; Vinod Mathrani; Rajesh Shrivastava; Jonathan Evans; Hayleigh Isaac; Sunil Bhandari
Journal:  BMC Nephrol       Date:  2017-11-30       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.